Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Rosca, Mariana G ^a   Mustata, Tiberiu G ^b   Kinter, Michael T ^c   Ozdemir, Aylin M ^a   Kern, Timothy S ^a   Szweda, Luke I ^a   Brownlee, Michael ^d   Monnier, Vincent M ^b   Weiss, Miriam F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Complex III; Methylglyoxal; Nephropathy; Proteomics

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; AMINOGUANIDINE; CYTOCHROME C; GLUCOSE; METHYLGLYOXAL; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FATTY ACID OXIDATION; GLYCATION; HYPERGLYCEMIA; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RAT; STREPTOZOCIN DIABETES; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 22344442393     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00415.2004     Document Type: Article

References (70)

1. Ahmad Z and Sherman F. Role of Arg-166 in yeast cytochrome c1. J Biol Chem 276: 18450-18456, 2001.
2. Alderton W, Cooper C, and Knowles R. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
3. Beisswenger P, Howell S, Nelson R, Mauer M, and Szwergold B. Alpha-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 31: 1358-1363, 2003.
4. Berry E, Guergova-Kuras M, Huang L, and Crofts A. Structure and function of cytochrome be complex. Annu Rev Biochem 69: 1005-1075, 2000.
5. Bolton W, Cattran D, Williams M, Adler S, Appel G, Cartwright K, Foiles P, Freedman B, Raskin P, Ratner R, Spinowitz B, Whittier F, Wuerth J, and Action Investigator Group I. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 24: 32-40, 2004.
6. Brownlee M. Glycation and diabetic complications. Diabetes 43: 836-841, 1994.
7. Buettner G. Use of ascorbate as test for the catalytic metals in simple buffers. Methods Enzymol 186: 125-127, 1990.
8. Casteilla L, Rigoulet M, and Penicaud L. Mitochondrial ROS metabolism: modulation by uncoupling proteins. IUBMB Life 52: 181-188, 2001.
9. Chance B, Sies H, and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979.
10. Chen Q, Vazquez E, Moghaddas S, and Hoppel C. Production of reactive oxygen species by mitochondria. Central role of complex III. J Biol Chem 278: 36027-36031, 2003.
11. Cocco T, Paola MD, Papa S, and Lorusso M. Localization of acidic residues involved in the proton pumping activity of the bovine heart mitochondrial bc1 complex. FEBS Lett 456: 37-40, 1999.
12. Du Y, Miller C, and Kern T. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35: 1491-1499, 2003.
13. Du Y, Smith M, Miller C, and Kern T. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80: 771-779, 2002.
14. Engel C, Mathieu M, Zeelen J, Hiltunen L, and Wierenga R. Crystal structure of enoyl- coenzyme A (CoA) hydratase at 2.5 A resolution: a spiral fold defines the CoA- binding pocket. EMBO J 15: 5135-5145, 1996.
15. Fersht A. Enzyme Structure and Mechanisms. New York:Freeman, 1985.
16. Flarsheim C, Grupp I, and Matub M. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol Heart Circ Physiol 271: H192-H202, 1996.
17. Forbes J, Thallas V, Thomas M, Founds H, Burns W, Jerums G, and Cooper M. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17: 1762-1764, 2003.
18. Giardino I, Fard A, Hatchell D, and Brownlee M. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47: 1114-1120, 1998.
19. Gredilla R, Phaneuf S, Selman C, Kendaiah S, Leeuwenburgh C, and Barja G. Short-term caloric restriction and sites of oxygen radical generation in kidney and skeletal muscle mitochondria. Ann NY Acad Sci 1019: 333-342, 2004.
20. Humphries K and Szweda L. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37: 15835-15841, 1998.
21. Humphries M, Yoo Y, and Szweda L. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 37: 552-557, 1998.
22. Hunte C, Solmaz S, and Lange C. Electron transfer between yeast cytochrome bcl complex and cytochrome c: a structural analysis (Abstract). Biochem Biophys Acta 1555: 21028, 2002.
23. Islam M, Tanaka M, Suzuki H, Torii K, Torii N, Hattori N, and Ozawa T. A complete cDNA sequence for core I protein subunit of human ubiquinol-cytochrome c reductase. Biochem Mol Biol Int 32: 797-805, 1994.
24. Jerums G, Panagiotopoulos S, Forbes J, Osicka T, and Cooper M. Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys 419: 55-62, 2003.
25. Kaneda K, Iwao J, Sakata N, and Takebayashi S. Correlation between mitochondrial enlargement in renal proximal tubules and microalbuminuria in rats with early streptozotocin-induced diabetes. Acta Pathol Jpn 42: 855-860, 1992.
26. Kang Y, Edwards L, and Thornalley P. Effect of methylglyoxal on human leukemia 60 cell growth: modification of DNA, growth arrest and induction of apoptosis. Leuk Res 20: 397-405, 1996.
27. Kaur G and Bhardwaj S. The impact of diabetes on CNS. Role of bioenergetic defects. Mol Chem Neuropathol 35: 119-131, 1998.
28. Keightley J, Shang L, and Kinter M. Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. Mol Cell Proteomics 3: 167-175, 2004.
29. Kelley D, Jing H, Menshikova E, and Ritov V. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2949, 2002.
30. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, and Haneda M. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxiadtive stress in diabetic nephropathy. Diabetes 52: 2603-2614, 2003.
31. Knecht K, Feather M, and Baynes J. Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stage of the Maillard reaction in vivo. Arch Biochem Biophys 294: 130-137, 1992.
32. Korshunov S, Skulachev V, and Starkov A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15-18, 1997.
33. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, and Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14: S250-S253, 2003.
34. Kristal B, Jackson C, Chung HY, Matsuda M, Nguyen H, and Yu B. Defects at center P underlie diabetes-associated mitochondrial dysfunction. Free Radic Biol Med 22: 823-833, 1997.
35. Ledenev A, Konstantinov A, Popova E, and Ruuge E. A simple assay of the superoxide generation rate with Tiron as an EPR-visible radical scavenger. Biochem Int 13: 391-396, 1986.
36. Lesnefsky E and Hoppel C. Ischemia-reperfusion injury in the aged heart; role of mitochondria. Arch Biochem Biophys 420: 287-297, 2003.
37. Liu Y, Fiskum G, and Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80: 780-787, 2002.
38. Lo T, Westwood M, McLellan A, Selwood T, and Thornalley P. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine. N alpha-acetylcysteine, N alpha-acetyl-lysine, and bovine serum albumin. J Biol Chem 269: 32299-32305, 1994.
39. Lopez M, Kristal B, Chernokalskaya E, Lazarev A, Shestopalov A, Bogdanova A, and Robinson M. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21: 3427-3440, 2000.
40. McLellan A, Phillips S, and Thornalley P. The assay of methylgtyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 206: 17-23, 1992.
41. McLellan A, Thornalley P, Benn J, and Sonksen P. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Colch) 87: 21-29, 1994.
42. Moghaddas S, Hoppel C, and Lesnefsky E. Aging defect at the Qo site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys 414: 59-66, 2003.
43. Molloy M. Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients. Anal Biochem 280: 1-10, 2000.
44. Monnier V, Sell D, Miyata S, Nagaraj R, Odetti P, and Lapolla A. Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia: relevance to diabetic nephropathy. Acta Diabetol 29: 130-135, 1992.
45. Monnier V, Vishwanath V, Frank K, Elmets C, Sauthot P, and Kohn R. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 314: 403-408, 1986.
46. Nishi S, Ueno M, Hisaki S, Iimo N, Iguchi S, Oyama Y, Imai N, Arakawa M, and Gejyo F. Ultrastructural characteristics of diabetic nephropathy. Med Electron Microsc 33: 65-73, 2002.
47. Nishikawa T, Edelstein D, Xue LD, Yamagishi S, Matsumura T, Kaneda Y, Yorek A, Beebe D, Gates J, Hammes H, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404: 787-790, 2000.
48. Nyengaard J, Chang K, Berhorst S, Reiser K, Williamson J, and Tilton R. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats. Diabetes 46: 94-106, 1997.
49. Obineche E, Mensah-Brown E, Chadranath S, Ahmed I, Naseer O, and Adem A. Morphological changes in the rat kidney following long-term diabetes. Arch Physiol Biochem 109: 241-245, 2001.
50. Papoulis A, Al-Abed Y, and Bucala R. Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycation endproduct. Biochemistry 34: 648-652, 1995.
51. Phillips SA and Thornalley PJ. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 212: 101-105, 1993.
52. Pitkanen S and Robinson B. Mitochondrial complex I deficiency leads to increased production of Superoxide radicals and induction of superoxide dismutase. J Clin Invest 98: 345-351, 1996.
53. Rago Jd Sohm F, Boccia C, Dujardin G, Trumpower B, and Slonimski P. A point mutation in the mitochondrial cytochrome b gene obviates the requirement for the nuclear encoded core protein 2 subunit in the cytochrome bcl complex in Saccharomyces cerevisiae. J Biol Chem 272: 4699-4704, 1997.
54. Rogers K, Friend W, and Higgins E. Metabolic and mitochondrial disturbances in streptozotocin-treated Sprague-Dawley and Sherman rats (42323). Proc Soc Exp Biol Med 182: 167-175, 1986.
55. Rosca M, Monnier V, Szweda L, and Weiss M. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am J Physiol Renal Physiol 283: F52-F59, 2002.
56. Rossignol R, Malgat M, Mazat J, and Letellier T. Threshold effect and tissue specificity. J Biol Chem 247: 33426-33432, 1999.
57. Sakurai S, Yonekura H, Yamamoto Y, Watanabe T, Tanaka N, Li H, Rahman A, Myint K, Kim C, and Yamamoto H. The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol 14: S259-S263, 2003.
58. Simon N, Jolliet P, Morin C, Zini R, Urien S, and Tillement J. Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kidney mitochondria. FEBS Lett 435: 25-28, 1998.
59. Soulis-Liparota T, Cooper M, Papazoglou D, Clark B, and Jerums G. Retardation by aminoguanidine of development of albumiunuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40: 1328-1334, 1991.
60. St-Pierre J, Buckingham J, Roebuck S, and Brand M. Topology of superoxide production from different sites in the mitochondrial electron chain. J Biol Chem 277: 44784-44790, 2002.
61. Taylor R, Birch-Machin M, Bartlett K, Lowerson S, and Turnbull D. The control of mitochondrial oxidation by complex III in rat muscle and liver mitochondria. Implications for our understanding of mitochondrial cytopathies in man. J Biol Chem 269: 3523-3528, 1994.
62. Thornalley P. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metab 3: 149-166, 1996.
63. Thornalley P. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419: 31-40, 2003.
64. Thornalley P, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, and Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375: 581-592, 2003.
65. Trumpower B. A concerted, alternating sites mechanism of ubiquinol oxidation by the dimeric cytochrome bcl complex. Biochem Biophys Acta 1555: 166-173, 2002.
66. Turko I, Li L, Kulwant S, Stuehr D, and Chang J. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. J Biol Chem 278: 33972-33977, 2003.
67. Turko I and Murad F. Quantitative protein profiling in heart mitochondria from diabetic rats. J Biol Chem 278: 35844-35849, 2003.
68. Wallace D. Mitochondrial diseases in man and mouse. Science 283: 1482-1488, 1999.
69. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, and Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF- beta overexpression in proximal tubular cells. Kidney Int 63: 464-473, 2003.
70. Yildiz G, Demiryurek A, Sahen-Erdemli I, and Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol 124: 905-910, 1998.